A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. nature.com Submitted by glawgii t3_105wwo9 on January 7, 2023 at 7:10 PM in science 184 comments 1,120
WallStreetKeks t1_j3lydvi wrote on January 9, 2023 at 2:14 PM Copium is being drank at record levels by pro vaxxers Permalink 1
Viewing a single comment thread. View all comments